ECCO 2021 - New Data On Therapy For Severely Active Ulcerative Colitis - YouTube
VEDOKIDS: Vedolizumab seems effective in paediatric IBD - Medical Conferences
Updated ECCO guidelines on management of UC in adults
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
Figure 2 from Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. | Semantic Scholar
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
European Crohn´s and Colitis Organisation - ECCO - P477 Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis
PDF) ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis (20.02.2009)
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease | NEJM
European Crohn´s and Colitis Organisation - ECCO - Evolving Treatment Options for Patients with Ulcerative Colitis (UC)
Children | Free Full-Text | Therapy Strategies for Children Suffering from Inflammatory Bowel Disease (IBD)—A Narrative Review
![PDF] Comparison of Clinical Guidelines for Ulcerative Colitis: ECCO, BSG, US and Japanese Guidelines with Reference to Surveillance | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fbf06deaa4f4dd6ac31dbcbd1bcd2f8fe5e271f1/3-Table1-2-1.png "PDF] Comparison of Clinical Guidelines for Ulcerative Colitis: ECCO, BSG, US and Japanese Guidelines with Reference to Surveillance | Semantic Scholar")
PDF] Comparison of Clinical Guidelines for Ulcerative Colitis: ECCO, BSG, US and Japanese Guidelines with Reference to Surveillance | Semantic Scholar
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
![PDF] Consensus guidelines for managing acute severe ulcerative colitis in children : a joint statement from ECCO , ESPGHAN , and the Pediatric IBD Porto Group Running title : Guidelines for managing](https://d3i71xaburhd42.cloudfront.net/441c40e34f9b62705d0e0c9a0f3ee686738c3031/30-Table1-1.png "PDF] Consensus guidelines for managing acute severe ulcerative colitis in children : a joint statement from ECCO , ESPGHAN , and the Pediatric IBD Porto Group Running title : Guidelines for managing")
PDF] Consensus guidelines for managing acute severe ulcerative colitis in children : a joint statement from ECCO , ESPGHAN , and the Pediatric IBD Porto Group Running title : Guidelines for managing
Ulcerative colitis - The Lancet
Colorectal carcinoma surveillance | ECCO E-Guide
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
IBD treatment plan 'needs to be a continuous conversation'
Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies - Calméjane - United European Gastroenterology Journal - Wiley Online Library
European Crohn´s and Colitis Organisation - ECCO - DOP69 Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses
ClinicalThought: New Data from ECCO 2022 - ClinicalThought - ECCO 2022 | CCO
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab
